Pharmaceutical Manufacturer Supply – Ceftriaxone Injectable

The contract involves the manufacture and supply of one unit of Ceftriaxone Injectable, produced under strict FDA-compliant and GMP-certified conditions to ensure pharmaceutical quality and safety. The product must align precisely with the Defense Logistics Agency’s Unit of Issue and packaging specifications, ensuring compatibility with military logistics and deployment requirements. Production and delivery are governed by regulatory standards that guarantee efficacy, sterility, and consistency, critical for use in military medical operations. This subcontract, issued under NAICS code 325412 for pharmaceutical and biological product manufacturing, is administered by the Department of Defense through the Defense Logistics Agency. The award is linked to a specific contract and delivery identification, with the performance and compliance obligations tied directly to federal procurement protocols. Although no set-aside designation or point of contact details are provided, the contract underscores a focused procurement effort to secure a single, high-integrity unit of a critical injectable antibiotic for defense medical support.